Stock Analysts’ Updated EPS Estimates for January 31st (AAPL, ABCB, AFYA, ALGM, AMZN, APPF, AVY, BCRX, BHLB, BIP)

Stock Analysts’ updated eps estimates for Friday, January 31st:

Apple (NASDAQ:AAPL) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $260.00 price target on the stock.

Apple (NASDAQ:AAPL) had its underweight rating reissued by analysts at KeyCorp. They currently have a $200.00 target price on the stock.

Ameris Bancorp (NASDAQ:ABCB) had its equal weight rating reaffirmed by analysts at Stephens. They currently have a $71.00 target price on the stock.

Afya (NASDAQ:AFYA) had its sell rating reiterated by analysts at Citigroup Inc.. Citigroup Inc. currently has a $15.00 target price on the stock, down from their previous target price of $18.00.

Allegro MicroSystems (NASDAQ:ALGM) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $30.00 target price on the stock.

Amazon.com (NASDAQ:AMZN) had its outperform rating reissued by analysts at Telsey Advisory Group. The firm currently has a $275.00 target price on the stock.

AppFolio (NASDAQ:APPF) had its neutral rating reissued by analysts at Piper Sandler. They currently have a $265.00 target price on the stock.

AppFolio (NASDAQ:APPF) had its overweight rating reiterated by analysts at Stephens. Stephens currently has a $295.00 target price on the stock.

AppFolio (NASDAQ:APPF) had its outperform rating reiterated by analysts at William Blair.

Avery Dennison (NYSE:AVY) had its outperform rating reaffirmed by analysts at Raymond James. Raymond James currently has a $208.00 target price on the stock, down from their previous target price of $218.00.

Avery Dennison (NYSE:AVY) had its buy rating reiterated by analysts at Truist Financial Co.. They currently have a $215.00 price target on the stock, down from their previous price target of $245.00.

BioCryst Pharmaceuticals (NASDAQ:BCRX) had its market outperform rating reiterated by analysts at JMP Securities. They currently have a $18.00 price target on the stock.

Berkshire Hills Bancorp (NYSE:BHLB) had its sector perform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $31.00 price target on the stock.

Brookfield Infrastructure Partners (NYSE:BIP) (TSE:BIP.UN) had its outperform rating reissued by analysts at Royal Bank of Canada. They currently have a $40.00 price target on the stock.

Boot Barn (NYSE:BOOT) had its overweight rating reaffirmed by analysts at Piper Sandler. The firm currently has a $181.00 target price on the stock, up from their previous target price of $179.00.

Cullen/Frost Bankers (NYSE:CFR) had its sector perform rating reaffirmed by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $144.00 target price on the stock.

Check Point Software Technologies (NASDAQ:CHKP) had its neutral rating reiterated by analysts at Guggenheim.

Check Point Software Technologies (NASDAQ:CHKP) had its buy rating reiterated by analysts at Truist Financial Co.. Truist Financial Co. currently has a $250.00 price target on the stock, up from their previous price target of $220.00.

Check Point Software Technologies (NASDAQ:CHKP) had its hold rating reiterated by analysts at Needham & Company LLC.

C.H. Robinson Worldwide (NASDAQ:CHRW) had its buy rating reaffirmed by analysts at Benchmark Co.. Benchmark Co. currently has a $125.00 target price on the stock.

Charter Communications (NASDAQ:CHTR) had its buy rating reiterated by analysts at Benchmark Co.. The firm currently has a $450.00 target price on the stock.

The Cigna Group (NYSE:CI) had its strong-buy rating reaffirmed by analysts at Raymond James. The firm currently has a $360.00 target price on the stock, down from their previous target price of $415.00.

Cipher Mining (NASDAQ:CIFR) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $7.50 price target on the stock.

Civista Bancshares (NASDAQ:CIVB) had its equal weight rating reaffirmed by analysts at Stephens. The firm currently has a $24.00 target price on the stock.

Coursera (NYSE:COUR) had its outperform rating reissued by analysts at Royal Bank of Canada. The firm currently has a $10.00 price target on the stock.

Deckers Outdoor (NYSE:DECK) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $246.00 price target on the stock.

Deckers Outdoor (NYSE:DECK) had its outperform rating reaffirmed by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $240.00 price target on the stock.

Deckers Outdoor (NYSE:DECK) had its neutral rating reaffirmed by analysts at Guggenheim.

Dover (NYSE:DOV) had its outperform rating reissued by analysts at Oppenheimer Holdings Inc.. They currently have a $225.00 price target on the stock, up from their previous price target of $220.00.

Dynatrace (NYSE:DT) had its neutral rating reaffirmed by analysts at Guggenheim.

Dynatrace (NYSE:DT) had its hold rating reissued by analysts at Needham & Company LLC.

Excelerate Energy (NYSE:EE) had its underweight rating reiterated by analysts at Morgan Stanley. They currently have a $29.00 price target on the stock, up from their previous price target of $25.00.

Estée Lauder Companies (NYSE:EL) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $100.00 price target on the stock.

Financial Institutions (NASDAQ:FISI) had its equal weight rating reissued by analysts at Stephens. They currently have a $33.00 target price on the stock.

First Merchants (NASDAQ:FRME) had its overweight rating reaffirmed by analysts at Piper Sandler. The firm currently has a $55.00 target price on the stock, up from their previous target price of $52.00.

First Merchants (NASDAQ:FRME) had its outperform rating reiterated by analysts at Raymond James. The firm currently has a $50.00 target price on the stock, up from their previous target price of $42.00.

GeoVax Labs (NASDAQ:GOVX) had its buy rating reiterated by analysts at D. Boral Capital. The firm currently has a $18.00 price target on the stock.

Hawkins (NASDAQ:HWKN) had its neutral rating reissued by analysts at BWS Financial. They currently have a $122.00 price target on the stock.

Informatica (NYSE:INFA) had its buy rating reaffirmed by analysts at Guggenheim. Guggenheim currently has a $37.00 target price on the stock.

Intel (NASDAQ:INTC) had its neutral rating reiterated by analysts at Cantor Fitzgerald. The firm currently has a $22.00 price target on the stock.

Intel (NASDAQ:INTC) had its hold rating reissued by analysts at Needham & Company LLC.

Intel (NASDAQ:INTC) had its hold rating reissued by analysts at Benchmark Co..

International Paper (NYSE:IP) had its buy rating reaffirmed by analysts at Truist Financial Co.. They currently have a $64.00 target price on the stock, down from their previous target price of $65.00.

International Paper (NYSE:IP) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $64.00 price target on the stock.

Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $9.00 price target on the stock.

Dorian LPG (NYSE:LPG) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. The firm currently has a $35.00 price target on the stock.

LPL Financial (NASDAQ:LPLA) had its market outperform rating reaffirmed by analysts at JMP Securities. The firm currently has a $435.00 price target on the stock.

Landstar System (NASDAQ:LSTR) had its hold rating reaffirmed by analysts at Benchmark Co..

LegalZoom.com (NASDAQ:LZ) had its market perform rating reiterated by analysts at JMP Securities.

Mastercard (NYSE:MA) had its outperform rating reaffirmed by analysts at Raymond James. They currently have a $640.00 target price on the stock, up from their previous target price of $614.00.

Mastercard (NYSE:MA) had its overweight rating reissued by analysts at Piper Sandler. They currently have a $635.00 target price on the stock, up from their previous target price of $591.00.

Mastercard (NYSE:MA) had its outperform rating reiterated by analysts at William Blair.

ManpowerGroup (NYSE:MAN) had its hold rating reaffirmed by analysts at Truist Financial Co.. The firm currently has a $70.00 price target on the stock, down from their previous price target of $74.00.

Mobileye Global (NASDAQ:MBLY) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $20.00 target price on the stock.

Mind Medicine (MindMed) (NASDAQ:MNMD) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $55.00 target price on the stock.

National Energy Services Reunited (NASDAQ:NESR) had its overweight rating reiterated by analysts at Barclays PLC. They currently have a $16.00 target price on the stock.

Nostrum Oil & Gas (LON:NOG) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 8 ($0.10) target price on the stock.

Quadrise (LON:QED) had its house stock rating reaffirmed by analysts at Shore Capital.

ResMed (NYSE:RMD) had its hold rating reissued by analysts at Needham & Company LLC.

Roper Technologies (NYSE:ROP) had its buy rating reiterated by analysts at Truist Financial Co.. They currently have a $675.00 target price on the stock, up from their previous target price of $665.00.

Roper Technologies (NYSE:ROP) had its strong-buy rating reissued by analysts at Raymond James. The firm currently has a $655.00 target price on the stock, up from their previous target price of $620.00.

SkyWest (NASDAQ:SKYW) had its outperform rating reiterated by analysts at Raymond James. The firm currently has a $130.00 target price on the stock, up from their previous target price of $120.00.

Atlassian (NASDAQ:TEAM) had its market perform rating reaffirmed by analysts at JMP Securities.

Atlassian (NASDAQ:TEAM) had its outperform rating reaffirmed by analysts at Raymond James. The firm currently has a $330.00 target price on the stock, up from their previous target price of $250.00.

Atlassian (NASDAQ:TEAM) had its outperform rating reissued by analysts at William Blair.

Atlassian (NASDAQ:TEAM) had its buy rating reiterated by analysts at Truist Financial Co.. Truist Financial Co. currently has a $350.00 price target on the stock, up from their previous price target of $300.00.

Tractor Supply (NASDAQ:TSCO) had its buy rating reissued by analysts at Guggenheim. Guggenheim currently has a $60.00 target price on the stock.

Under Armour (NYSE:UAA) had its market perform rating reissued by analysts at Telsey Advisory Group. They currently have a $10.00 price target on the stock.

Uber Technologies (NYSE:UBER) had its hold rating reaffirmed by analysts at Benchmark Co..

Uber Technologies (NYSE:UBER) had its market perform rating reaffirmed by analysts at JMP Securities.

United Rentals (NYSE:URI) had its buy rating reissued by analysts at Truist Financial Co.. Truist Financial Co. currently has a $956.00 target price on the stock, down from their previous target price of $963.00.

Visa (NYSE:V) had its outperform rating reaffirmed by analysts at Raymond James. They currently have a $393.00 price target on the stock, up from their previous price target of $374.00.

Visa (NYSE:V) had its outperform rating reaffirmed by analysts at William Blair.

Valneva (NASDAQ:VALN) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $18.00 target price on the stock.

Viavi Solutions (NASDAQ:VIAV) had its outperform rating reiterated by analysts at Northland Securities. Northland Securities currently has a $14.00 price target on the stock, up from their previous price target of $13.00.

Viavi Solutions (NASDAQ:VIAV) had its buy rating reiterated by analysts at Stifel Nicolaus. The firm currently has a $13.00 price target on the stock, up from their previous price target of $12.00.

Vir Biotechnology (NASDAQ:VIR) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $110.00 price target on the stock.

Vertex Pharmaceuticals (NASDAQ:VRTX) had its hold rating reissued by analysts at Needham & Company LLC.

Vertex Pharmaceuticals (NASDAQ:VRTX) had its outperform rating reaffirmed by analysts at William Blair.

Vertex Pharmaceuticals (NASDAQ:VRTX) had its overweight rating reissued by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $480.00 price target on the stock.

Waste Management (NYSE:WM) had its outperform rating reiterated by analysts at William Blair.